Unexpectedly high burden of rotavirus gastroenteritis in very young infants

BMC Pediatrics

Volumn 10, Issue , 2010, Pages

  Clark, H Fred ^a   Marcello, Amy E ^a   Lawley, Diane ^a   Reilly, Megan ^a   DiNubile, Mark J ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ROTAVIRUS VACCINE; VIRUS ANTIGEN;

AGE DISTRIBUTION; ARTICLE; CHILD; DISEASE SURVEILLANCE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; FEMALE; GASTROENTERITIS; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PATIENT MONITORING; PATIENT REFERRAL; PRESCHOOL CHILD; ROTAVIRUS INFECTION; SEROTYPE; UNIVERSITY HOSPITAL; COMMUNICABLE DISEASE; HOSPITALIZATION; UNITED STATES; VIROLOGY;

COMMUNITY-ACQUIRED INFECTIONS; FEMALE; GASTROENTERITIS; HOSPITALIZATION; HUMANS; INCIDENCE; INFANT; MALE; PENNSYLVANIA; ROTAVIRUS INFECTIONS;

EID: 77953300859     PISSN: None     EISSN: 14712431     Source Type: Journal    
DOI: 10.1186/1471-2431-10-40     Document Type: Article

References (46)

1. Clark HF, Lawley DA, Mallette LA, DiNubile MJ, Hodinka RL. Decline in cases of rotavirus gastroenteritis presenting to The Children's Hospital of Philadelphia after introduction of a pentavalent rotavirus vaccine. Clin Vaccine Immunol 2009, 16:382-86. 10.1128/CVI.00382-08, 2650872, 19158283.
2. Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006, 354:11-22. 10.1056/NEJMoa052434, 16394298.
3. Vesikari T, Matson DO, Dennehy P, et al. Safety and efficacy of pentavalent human-bovine (WC3) reassortant rotavirus vaccine in preventing rotavirus gastroenteritis and reducing associated healthcare resource utilization. N Engl J Med 2006, 354:23-33. 10.1056/NEJMoa052664, 16394299.
4. Cicirello HG, Das BK, Gupta A, et al. High prevalence of rotavirus infection among neonates born at hospitals in Delhi, India: predisposition of newborns for infection with unusual rotavirus. Ped Infect Dis J 1994, 13:720-724.
5. Dormitzer PR, . Rotaviruses Principles and Practice of Infectious Diseases. 2005, 1902-1913. Elsevier, Churchill-Livingstone. Philadelphia, Mandel, GL, Bennett, JE, and Dolin R, Sixth, Chapter 146, Rotaviruses.
6. Fischer TK. Incidence of hospitalizations due to rotavirus gastroenteritis in Denmark. Acta Paediatr 2001, 90:1073-1075. 10.1080/080352501316978183, 11683198.
7. Fischer TK, Viboud C, Parashar U, et al. Hospitalizations and deaths from diarrhea and rotavirus among children <5 years of age in the United States, 1993-2003. J Infect Dis 2007, 195:1117-1125. 10.1086/512863, 17357047.
8. Ford-Jones EL, Wang E, Petric M, Corey P, Moineddin R, Fearon M. Rotavirus-associated diarrhea in outpatient settings and child care centers. The Greater Toronto Area/Peel Region PRESI Study Group. Pediatric Rotavirus Epidemiology Study for Immunization. Arch Pediatr Adolesc Med 2000, 154:586-593.
9. Forster J, Guarino A, Parez N, et al. Hospital-based surveillance to estimate the burden of rotavirus gastroenteritis among European children younger than 5 years of age. Pediatrics 2009, 123:e393-e400. 10.1542/peds.2008-2088, 19254975.
10. Georges-Courbot MC, Monges J, Beraud-Cassel AM, Gouandjika I, Georges AJ. Prospective longitudinal study of rotavirus infections in children from birth to two years of age in Central Africa. Ann Inst Pasteur Virol 1988, 139:421-428. 10.1016/S0769-2617(88)80077-7, 3214595.
11. Gil A, Carrasco P, Jimenez R, San Martin M, Oyaguez I, Gonzalez A. Burden of hospitalizations attributable to rotavirus infection in children in Spain, period 1999-2000. Vaccine 2004, 22:2221-2225. 10.1016/j.vaccine.2003.11.037, 15149780.
12. Grimwood K, Huang QS, Cohet C, et al. Rotavirus hospitalisation in New Zealand children under 3 years of age. J Paediatr Child Health 2006, 42:196-203. 10.1111/j.1440-1754.2006.00829.x, 16630321.
13. Jin S, Kilgore PE, Holman RC, Clarke MJ, Gangarosa EJ, Glass RI. Trends in hospitalizations for diarrhea in United States children from 1979 through 1992: estimates of the morbidity associated with rotavirus. Pediatr Infect Dis J 1996, 15:397-404. 10.1097/00006454-199605000-00004, 8724060.
14. Kapikan AZ, Kim HW, Wyatt RG, et al. Human reovirus-like agent as the major pathogen associated with "winter" gastroenteritis in hospitalized infants and young children. N Engl J Med 1976, 294:965-972.
15. Lynch M, O'Halloran F, Whyte D, Fanning S, Cryan B, Glass RI. Rotavirus in Ireland: national estimates of disease burden, 1997 to 1998. Pediatr Infect Dis J 2001, 20:693-698. 10.1097/00006454-200107000-00010, 11465842.
16. Malek MA, Curns AT, Holman RC, et al. Diarrhea- and rotavirus-associated hospitalizations among children less than 5 years of age: United States, 1997 and 2000. Pediatrics 2006, 17:1887-1892.
17. Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 2003, 9:565-572.
18. Patel M, Pedreira C, De Oliveira LH, et al. Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua. JAMA 2009, 301:2243-2251. 10.1001/jama.2009.756, 19491186.
19. Rodriguez WJ, Kim HW, Brandt CD, et al. Rotavirus gastroenteritis in the Washington, DC, area: incidence of cases resulting in admission to the hospital. Am J Dis Child 1980, 134:777-779.
20. Ward RL, Bernstein DI, Staat MA, . Rotaviruses Textbook of Pediatric Infectious Diseases. 2009, 2245-2270. Feigin RD, Cherry JD, Demmler-Harrison GJ, Kaplan SL, Sixth, Chapter 185, Rotaviruses.
21. Bettencourt JA, Arbor E, Malysz AS, Oravec R, Dias C. Seasonal and age distribution of rotavirus infection in Porto Alegre-Brazil. Braz J Infect Dis 2000, 4:279-283.
22. Rivest P, Proulx M, Lonergan G, Lebel MH, Bedard L. Hospitalizations for gastroenteritis: the role of rotavirus. Vaccine 2004, 22:2013-2017. 10.1016/j.vaccine.2003.10.029, 15121314.
23. Rodriguez WJ, Kim HW, Brandt CD, et al. Longitudinal study of rotavirus infection and gastroenteritis in families served by a pediatric medical practice: clinical and epidemiologic observations. Pediatr Infect Dis J 1987, 6:170-176. 10.1097/00006454-198702000-00006, 3031575.
24. Duffy LC, Byers TE, Riepenhoff-Talty M, La Scolea LJ, Zielezny M, Ogra PL. The effects of infant feeding on rotavirus-induced gastroenteritis: a prospective study. Am J Public Health 1986, 76:259-263. 10.2105/AJPH.76.3.259, 1646548, 3004238.
25. Elias MM. Distribution and titres of rotavirus antibodies in different age groups. J Hyg (Lond) 1977, 79:365-372. 2129953, 200676.
26. Misra S, Sabui TK, Basu S. A prospective study of rotavirus diarrhea in children under 1 year of age. Clin Pediatr (Phila) 2007, 46:683-688. 10.1177/0009922807300700, 17554140.
27. Centers for Disease Control Prevention of rotavirus gastroenteritis among infants and children. MMWR 2006, 55:1-13. Centers for Disease Control.
28. Centers for Disease Control Rotavirus vaccination coverage and adherence to the advisory committee on immunization practices (ACIP)-recommended vaccination schedule - United States, February 2006-May 2007. MMWR 2008, 57:398-401. Centers for Disease Control.
29. Clark HF, Lawley DA, Schaffer A, et al. Assessment of the epidemic potential of a new strain of rotavirus associated with the novel G9 serotype which caused an outbreak in the United States for the first time in the 1995-1996 season. J Clin Microbiol 2004, 42:1434-1438. 10.1128/JCM.42.4.1434-1438.2004, 387540, 15070985.
30. Smith MJ, Clark HF, Lawley D, et al. The clinical and molecular epidemiology of community- and healthcare-acquired rotavirus gastroenteritis. Pediatr Infect Dis J 2008, 27:54-58. 10.1097/INF.0b013e31814b279d, 18162939.
31. Torok TJ, Kilgore PE, Clarke MJ, Holman RC, Bresee JS, Glass RI. Visualizing geographic and temporal trends in rotavirus activity in the United States, 1991 to 1996. Pediatr Infect Dis J 1997, 16:941-946. 10.1097/00006454-199710000-00007, 9380468.
32. Gouvea V, Ho MS, Glass R, et al. Serotypes and electropherotypes of human rotavirus in the USA: 1987-1989. J Infect Dis 1990, 162:362-367.
33. DiStefano D, Kraiochkine N, Mallette L, et al. Novel rotavirus VP7 typing assay using a one-step reverse transcriptase PCR protocol and product sequencing and utility of the assay for epidemiological studies and strain characterization, including serotype subgroup analysis. J Clin Microbiol 2005, 43:5876-5880. 10.1128/JCM.43.12.5876-5880.2005, 1317171, 16333070.
34. Coffin SE, Zaoutis TE, Rosenquist AB, et al. Incidence, complications, and risk factors for prolonged stay in children hospitalized with community-acquired influenza. Pediatrics 2007, 119:740-748. 10.1542/peds.2006-2679, 17403845.
35. Coffin SE, Marchant J, Sawyer M, et al. Impact of acute rotavirus gastroenteritis on pediatric outpatient practices in the United States. Pediatr Infect Dis J 2006, 25:584-589. 10.1097/01.inf.0000220251.27595.74, 16804426.
36. Parashar UD, Holman RC, Bresee JS, et al. Epidemiology of diarrheal disease among children enrolled in four West Coast health maintenance organizations. Vaccine Safety Datalink Team. Pediatr Infect Dis J 1998, 17:605-611. 10.1097/00006454-199807000-00006, 9686726.
37. Salinas B, Gonzalez G, Gonzalez R, Escalona, Materan M, Schael IP. Epidemiologic and clinical characteristics of rotavirus disease during five years of surveillance in Venezuela. Pediatr Infect Dis J 2004, 23:S161-S167. 10.1097/01.inf.0000142465.25992.c3, 15502696.
38. Truant AL, Chonmaitree T. Incidence of rotavirus infection in different age groups of pediatric patients with gastroenteritis. J Clin Microbiol 1982, 16:568-569. 272414, 6290533.
39. Daskalaki I, Spain CV, Long SS, Watson B. Implementation of rotavirus immunization in Philadelphia, Pennsylvania: high levels of vaccine ineligibility and off-label use. Pediatrics 2008, 122:e33-e38. 10.1542/peds.2007-2464, 18595974.
40. Goveia MG, DiNubile MJ, Dallas MJ, Heaton PM, Kuter BJ. Efficacy of pentavalent human-bovine (WC3) reassortant rotavirus vaccine based on breastfeeding frequency. Pediatr Infect Dis J 2008, 27:656-658. 10.1097/INF.0b013e318168d29e, 18520448.
41. Goveia MG, Rodriguez ZM, Dallas MJ, et al. Safety and efficacy of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine in healthy premature infants. Pediatr Infect Dis J 2007, 26:1099-1104. 10.1097/INF.0b013e31814521cb, 18043445.
42. Nguyen TV, Yuan L, Pa MS, Jeong KI, Gonzalez AM, Iosef C. Low titer maternal antibodies can both enhance and suppress B cell responses to a combined live attenuated human rotavirus and VLP-ISCOM vaccine. Vaccine 2006, 24:2302-2316. 10.1016/j.vaccine.2005.11.043, 16361002.
43. Patel MM, Clark AD, Glass RI, et al. Broadening the age restriction for initiating rotavirus vaccination in regions with high rotavirus mortality: benefits of mortality reduction versus risk of fatal intussusception. Vaccine 2009, 27:2916-2922. 10.1016/j.vaccine.2009.03.016, 19428901.
44. Shim E, Feng Z, Martcheva M, Castillo-Chavez C. An age-structured epidemic model of rotavirus with vaccination. J Math Biol 2006, 53:719-746. 10.1007/s00285-006-0023-0, 16915388.
45. Vesikari T, Karvonen A, Forrest BD, Hoshino Y, Chanock RM, Kapikian AZ. Neonatal administration of rhesus rotavirus tetravalent vaccine. Pediatr Infect Dis J 2006, 25:118-22. 10.1097/01.inf.0000199288.98370.71, 16462287.
46. Vesikari T, Ruuska R, Delem A, Andre FE. Neonatal rotavirus vaccination with RIT 4237 bovine rotavirus vaccine: a preliminary report. Pediatr Infect Dis J 1987, 6:164-169. 10.1097/00006454-198702000-00005, 3031574.